Generative AI in healthcare to hit $30.4b by 2032 on imaging boom

Asia-Pacific is expected to register the highest compound annual growth rate.

The global generative artificial intelligence in healthcare market is projected to reach $30.4b by 2032, expanding at a compound annual growth rate of 34.9%, according to an Allied Market Research report.

It is being driven by a surge in the adoption of generative AI for medical image analysis, AI-enabled workflow automation, and precision medicine use powered by data-driven decision-making.

By application, the diagnosis segment dominated the market in 2022, accounting for more than two-fifths of total market revenue.

Meanwhile, the drug discovery segment is anticipated to record significant growth during the forecast period, as pharmaceutical companies increasingly leverage generative AI.

North America held the largest revenue share in the global market in 2022, but Asia-Pacific is expected to register the highest compound annual growth rate during the forecast period.

The region's growth is supported by digital health investment, healthcare expenditure, growing awareness of AI-powered diagnostics, and large-scale adoption of telemedicine and health informatics platforms.